Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amvofer C is an oral nutritional supplement developed by Amvia Biotech, containing a combination of carbonyl iron, folic acid, vitamin B12, and zinc. It is indicated for the treatment and prevention of iron deficiency anemia and for general nutritional support. Carbonyl iron is a highly pure form of elemental iron that is absorbed slowly, leading to improved tolerability and reduced gastrointestinal irritation compared to ferrous salts. Folic acid and vitamin B12 are essential for the maturation of red blood cells and DNA synthesis, while zinc serves as a vital cofactor for various enzymatic reactions and immune system maintenance. The product is available in capsule and tablet formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carbonyl iron + folic acid + cyanocobalamin + zinc.